loadpatents
name:-0.045694828033447
name:-0.030239105224609
name:-0.017132997512817
Cee; Victor J. Patent Filings

Cee; Victor J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cee; Victor J..The latest application filed is for "inhibitors of kras g12c and methods of using the same".

Company Profile
15.31.41
  • Cee; Victor J. - Thousand Oaks CA
  • Cee; Victor J. - Mansfield MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Dosing of KRAS inhibitor for treatment of cancers
Grant 11,426,404 - Henary , et al. August 30, 2
2022-08-30
Inhibitors Of Kras G12c And Methods Of Using The Same
App 20220213101 - LANMAN; Brian Alan ;   et al.
2022-07-07
Kras G12c Inhibitors And Methods Of Using The Same
App 20220175782 - ALLEN; John Gordon ;   et al.
2022-06-09
Kras G12c Inhibitors And Methods Of Using The Same
App 20220168280 - LANMAN; Brian Alan ;   et al.
2022-06-02
Inhibitors of KRAS G12C and methods of using the same
Grant 11,306,087 - Lanman , et al. April 19, 2
2022-04-19
Substituted piperazines as KRAS G12C inhibitors
Grant 11,285,156 - Allen , et al. March 29, 2
2022-03-29
KRAS G12C inhibitors and methods of using the same
Grant 11,285,135 - Lanman , et al. March 29, 2
2022-03-29
Kras G12c Inhibitors And Methods Of Using The Same
App 20220002298 - CHEN; Jian ;   et al.
2022-01-06
KRAS G12C inhibitors and methods of using the same
Grant 11,096,939 - Booker , et al. August 24, 2
2021-08-24
KRAS G12C inhibitors and methods of using the same
Grant 11,090,304 - Allen , et al. August 17, 2
2021-08-17
KRAS G12C inhibitors and methods of using the same
Grant 11,053,226 - Shin , et al. July 6, 2
2021-07-06
KRAS G12C inhibitors and methods of using the same
Grant 11,045,484 - Wurz , et al. June 29, 2
2021-06-29
KRAS G12C inhibitors and methods of using the same
Grant 10,988,485 - Minatti , et al. April 27, 2
2021-04-27
Kras G12c Inhibitors And Methods Of Using The Same
App 20210009577 - LANMAN; Brian Alan ;   et al.
2021-01-14
Dosing Of Kras Inhibitor For Treatment Of Cancers
App 20200360374 - HENARY; Haby ;   et al.
2020-11-19
Inhibitors Of Kras G12c And Methods Of Using The Same
App 20200207766 - LANMAN; Brian Alan ;   et al.
2020-07-02
Kras G12c Inhibitors And Methods Of Using The Same
App 20200165231 - SHIN; Youngsook ;   et al.
2020-05-28
Inhibitors of KRAS G12C and methods of using the same
Grant 10,640,504 - Lanman , et al.
2020-05-05
Kras G12c Inhibitors And Methods Of Using The Same
App 20200069657 - LANMAN; Brian Alan ;   et al.
2020-03-05
Kras G12c Inhibitors And Methods Of Using The Same
App 20200055845 - LANMAN; Brian Alan ;   et al.
2020-02-20
Kras G12c Inhibitors And Methods Of Using The Same
App 20200030324 - BOOKER; Shon ;   et al.
2020-01-30
KRAS G12C inhibitors and methods of using the same
Grant 10,532,042 - Lanman , et al. Ja
2020-01-14
KRAS G12C inhibitors and methods of using the same
Grant 10,519,146 - Lanman , et al. Dec
2019-12-31
Kras G12c Inhibitors And Methods Of Using The Same
App 20190374542 - ALLEN; John Gordon ;   et al.
2019-12-12
Kras G12c Inhibitors And Methods Of Using The Same
App 20190375749 - CHEN; Jian ;   et al.
2019-12-12
Kras G12c Inhibitors And Methods Of Using The Same
App 20190343838 - Allen; John Gordon ;   et al.
2019-11-14
Kras G12c Inhibitors And Methods Of Using The Same
App 20190345169 - MINATTI; Ana Elena ;   et al.
2019-11-14
Kras G12c Inhibitors And Methods Of Using The Same
App 20190336514 - WURZ; Ryan Paul ;   et al.
2019-11-07
Inhibitors Of Kras G12c And Methods Of Using The Same
App 20190077801 - LANMAN; Brian Alan ;   et al.
2019-03-14
Kras G12c Inhibitors And Methods Of Using The Same
App 20180334454 - LANMAN; Brian Alan ;   et al.
2018-11-22
Kras G12c Inhibitors And Methods Of Using The Same
App 20180177767 - LANMAN; Brian Alan ;   et al.
2018-06-28
Pyrazole amide derivative
Grant 9,365,522 - Beck , et al. June 14, 2
2016-06-14
Azole compounds as PIM inhibitors
Grant 9,321,756 - Wang , et al. April 26, 2
2016-04-26
Pyrazole Amide Derivative
App 20150266824 - Beck; Hilary Plake ;   et al.
2015-09-24
Bicyclic compounds as Pim inhibitors
Grant 9,090,593 - Wang , et al. July 28, 2
2015-07-28
Aurora Kinase Modulators and Method of Use
App 20140336182 - CEE; Victor J. ;   et al.
2014-11-13
Inhibitors of PI3 kinase and/or mTOR
Grant 8,772,480 - Andrews , et al. July 8, 2
2014-07-08
Azole Compounds as PIM Inhibitors
App 20140187553 - Wang; Hui-Ling ;   et al.
2014-07-03
Aurora kinase modulators and method of use
Grant 8,686,155 - Cee , et al. April 1, 2
2014-04-01
Aurora Kinase Modulators And Method Of Use
App 20140066430 - CEE; Victor J. ;   et al.
2014-03-06
Bicyclic Compounds As Pim Inhibitors
App 20140031360 - Wang; Hui-Ling ;   et al.
2014-01-30
Aurora kinase modulators and method of use
Grant 8,557,816 - Geuns-Meyer , et al. October 15, 2
2013-10-15
Protein kinase modulators and method of use
Grant 8,476,434 - Geuns-Meyer , et al. July 2, 2
2013-07-02
Inhibitors of PI3 Kinase and/or mTOR
App 20130079303 - ANDREWS; Kristin L. ;   et al.
2013-03-28
S1p1 Receptor Agonists And Use Thereof
App 20120129828 - Cee; Victor J. ;   et al.
2012-05-24
Aurora Kinase Modulators and Method of Use
App 20110263530 - CEE; Victor J. ;   et al.
2011-10-27
Aurora kinase modulators and method of use
Grant 8,022,221 - Cee , et al. September 20, 2
2011-09-20
S1P Receptor Modulating Compounds and Use Thereof
App 20110212940 - Burli; Roland ;   et al.
2011-09-01
Protein Kinase Modulators And Method Of Use
App 20110201602 - GEUNS-MEYER; Stephanie D. ;   et al.
2011-08-18
S1P receptor modulating compounds and use thereof
Grant 7,919,519 - Burli , et al. April 5, 2
2011-04-05
Protein kinase modulators and method of use
Grant 7,880,000 - Geuns-Meyer , et al. February 1, 2
2011-02-01
Multi-cyclic compounds and method of use
Grant 7,868,177 - Cee , et al. January 11, 2
2011-01-11
S1P1 receptor agonists and use thereof
Grant 7,842,685 - Cee , et al. November 30, 2
2010-11-30
Inhibitors Of Pi3 Kinase And/or Mtor
App 20100273764 - Andrews; Kristin ;   et al.
2010-10-28
Heteroaryl-substituted alkyne compounds and method of use
Grant 7,776,869 - Chaffee , et al. August 17, 2
2010-08-17
Heteroaryl-substituted Alkyne Compounds And Method Of Use
App 20100160283 - Chaffee; Stuart C. ;   et al.
2010-06-24
S1P1 receptor agonists and use thereof
App 20100029611 - Cee; Victor J. ;   et al.
2010-02-04
Aurora kinase modulators and method of use
Grant 7,560,551 - Cee , et al. July 14, 2
2009-07-14
Aurora kinase modulators and method of use
App 20090163501 - Cee; Victor J. ;   et al.
2009-06-25
S1P receptor modulating compounds and use thereof
App 20080027036 - Burli; Roland ;   et al.
2008-01-31
Multi-cyclic compound and method of use
App 20070213325 - Cee; Victor J. ;   et al.
2007-09-13
Aurora kinase modulators and method of use
App 20070185111 - Cee; Victor J. ;   et al.
2007-08-09
Aryl nitrogen-containing bicyclic compounds and methods of use
App 20070054916 - Patel; Vinod F. ;   et al.
2007-03-08
Heteroaryl-substituted alkyne compounds and method of use
App 20060217380 - Chaffee; Stuart C. ;   et al.
2006-09-28
Protein kinase modulators and method of use
App 20060009453 - Geuns-Meyer; Stephanie D. ;   et al.
2006-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed